<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00190294</url>
  </required_header>
  <id_info>
    <org_study_id>P011017</org_study_id>
    <nct_id>NCT00190294</nct_id>
  </id_info>
  <brief_title>Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW</brief_title>
  <official_title>Comparison Expectant With Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compared the interest of one week expectancy vs immediate medical treatment in the taking
      care of the evacuation of the no evolutionary pregnancies before 13 GW.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized control trial comparing one week expectancy vs immediate medical treatment
      (mifepristone 200mg and misoprostol 400ug) in the taking care of the evacuation of the no
      evolutionary pregnancies before 13 GW.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <primary_completion_date type="Actual">September 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of surgical evacuation in each group</measure>
    <time_frame>during de study</time_frame>
    <description>Number of surgical evacuation in each group</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Pregnancy Complications</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MIFEPRISTONE 200 mg and misoprostol 400 µg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MIFEPRISTONE 200 mg and misoprostol 400 µg</intervention_name>
    <description>MIFEPRISTONE 200 mg and misoprostol 400 µg</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Agreed women aged over 18 yrs old

        Non evolutive pregnancy before 13GW :

          -  Non evolutive pregnancy with no fetal cardiac activity

          -  Non evolutive pregnancy with embryonic structures

          -  Trophoblastic material in uterine cavity P bhCG &lt; 10UI/L

        Exclusion criteria:

          -  Age &lt; 18 years

          -  pregnancy evolutionary

          -  not evolutionary pregnancy after 13 weeks of amenorrhoea characterized by the presence
             of an scan image intra-uterine ANECHOGENE furthermore of 50mm of diameter

          -  amenorrhoea of more than 13 weeks

          -  pregnancy twin

          -  pregnancy molar

          -  pregnancy extra-uterine

          -  Extra-uterine pregnancy

          -  one or many contraindications in the mifepristone:

          -  Allergy known about the MIFEPRISTONE

          -  Incapacity suprarenal

          -  corticosteroid therapy in the long price

          -  confusions of the haemostasis (thrombopenia &lt; in 100000 / mm3)

          -  anaemia (rate Hg &lt; in 9 g / dl)

          -  contraindication in the misoprostol

          -  allergy known about PROSTAGLANDINES

          -  BEANCE cervical
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Rosenberg</last_name>
    <role>Study Chair</role>
    <affiliation>Poissy Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Poissy Hospital</name>
      <address>
        <city>Poissy</city>
        <zip>78303</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>April 29, 2011</last_update_submitted>
  <last_update_submitted_qc>April 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Isabelle Brindel</name_title>
    <organization>Department Clinical Research of developpement</organization>
  </responsible_party>
  <keyword>Pregnancy Complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
    <mesh_term>Mifepristone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

